VANCOUVER, BC – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, announced that it… Read More
Endometriosis remains largely understudied despite being a relatively common condition. Affecting about one in 10 women of reproductive age, its occurrence among the Canadian population is only slightly behind type… Read More
Novel MDMA-like drug could be used for numerous neurological and psychiatric indications TORONTO, ON – PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused… Read More
OTTAWA, ON – Innovative Medicines Canada (IMC) is pleased to announce Dr. Bettina Hamelin has been appointed as its new President, effective April 8, 2024. Dr. Hamelin, PharmD, EMBA, comes to IMC… Read More
Research institutions in the United States, Canada, Israel, and Belgium, including Johns Hopkins University, will study PEX010, Filament’s botanical psilocybin drug candidate VANCOUVER, BC – Filament Health Corp. (OTCQB:FLHLF) (NEO:FH) (FSE:7QS) (“Filament” or… Read More
